Influence of triple antithrombotic therapy based on rivaroxaban in different courses on long-term prognosis in elderly patients with ACS complicated by AF after PCI

Liu Yantao; Zhang Yanyan; Li Yening; Xu Huanhuan

doi:10.3969/j.issn.1674-4055.2021.09.19

Home>Articles>Influence of triple antithrombotic therapy based on rivaroxaban in different courses on long-term prognosis in elderly patients with ACS complicated by AF after PCI

DOI: 10.3969/j.issn.1674-4055.2021.09.19

Influence of triple antithrombotic therapy based on rivaroxaban in different courses on long-term prognosis in elderly patients with ACS complicated by AF after PCI

Liu Yantao

Zhang Yanyan

Li Yening

Xu Huanhuan

Machine-generated Keywords：

Publication Date：2021-09-28

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 1104-1107 )

Chinese Journal of Evidence-Bases Cardiovascular Medicine

ISTIC

ISSN：1674-4055

Year, Vol.(Issue)：2021,13(9)